Biochip technology development is expensive due to the requirement for substantial R&D and competent developers, resulting in a high end-product cost. Microscale probes formatted on glass surfaces are used in the biochip system, which necessitates the employment of automated robotic tools for handling and scanning micro-scale materials. Due to the necessity for specific procedures and tools for deployment, this technology is very expensive. The expensive cost of Biochips has slowed their commercial adoption. Furthermore, lack of knowledge of biochips, particularly in underdeveloped nations, is constraining revenue growth.
A biochip is a little medical gadget that has a large number of microarrays for performing many biochemical reactions at the same time. Biochips are equipped with a variety of biosensors that allow for the detection of a variety of biological analytes such as enzymes, proteins, DNA, biological molecules, antibodies, and so on. Drug development, in-vitro diagnostics, gene expression profiling, single nucleotide polymorphism genotyping, agricultural biotechnology, and other applications employ biochips. As a result, they are frequently used by pharmaceutical and biotechnology businesses, academic and research laboratories, and healthcare facilities.
Explore More@ https://bit.ly/3n61GsQ
